A First Look at the Latest Clinic-Exclusive Innovations from ALLSKIN | MED
Partner Exclusive Online Training Webinar:
Monday 27th April | 13:00
Join your AesthetiCare Clinic Development Managers Rebecca, Jenny and Leanne for an exclusive 60 minute introduction and training session on the NEW ALLSKIN | MED Retinoid Portfolio and Collagen Activation Barrier+ Treatment Plan.
With extensive experience supporting partner clinics across the UK, we’ll walk you through the latest product launches, formulation innovations and clinical technologies from ALLSKIN | MED – giving your clinic an informed head start before these become more widely available.
What you’ll learn
Groundbreaking Innovation:
RETINDUO® Technology
Forming the foundation of the NEW ALLSKIN | MED retinoid portfolio, discover Cantabria Labs’ advanced RETINDUO® dual-pathway retinoid technology, delivering triple innovation through multi-pathway retinoid activation.
Pure retinol in microsponges for long-lasting effect
Retinal AOX Tech-encapsulated retinal for immediate and controlled action
Optimised by bioavailability-boosting natural ingredients to optimise retinoid activity within the skin
NEW Clinic-Exclusive
ALLSKIN | MED Retinoid Portfolio
Built on RETINDUO® technology, the NEW ALLSKIN | MED Retinoid Portfolio combines clinically proven retinoid innovation with evidence-based dermatological ingredients in six new products, scientifically developed to elevate the treatment of key skin indications practitioners most commonly treat in medical aesthetic clinics.
ALLSKIN | MED
Retinoid Pigment Control Emulsions
Hyperpigmentation &
Photodamaged Skin
ALLSKIN | MED
Retinoid Renewal
Serums
Ageing &
Photodamaged Skin
ALLSKIN | MED
Retinoid Texture Repair
Emulsion
Textural Concerns &
Acne-Prone Skin
NEW ALLSKIN | MED
Collagen Activation Barrier+ Treatment Plan
Enhance Treatment outcomes by 50%1
Significantly reduce
downtime1
Improve barrier repair,
hydration + comfort1
A clinically proven, medical-grade home-use treatment plan designed to enhance treatment results from both ablative and non-ablative procedures by up to 50%, while accelerating skin recovery.1
This advanced three-step treatment plan, powered by SCA® PRO Growth Factor Technology and Reoxderm® Antioxidant Technology, combines targeted fibroblast stimulation with structured barrier reinforcement to support skin regeneration before, during, and after treatment.
Who Should Join
This session is ideal for clinic owners, managers and skincare practitioners who want to stay ahead of the curve, expand their treatment offering and ensure their team is confident with the latest innovations in retinoid and barrier protection technology.
Event Details:
Date: Monday, 27th April 2026
Time: 13:00 – 14:00
Format: Online Webinar (link provided upon registration)
Duration: 45 minutes
Cost: Free – exclusive to ALLSKIN | MED Partner Clinics
Reserve Your Place Now
Places are limited to ensure an interactive session. Register now to guarantee your spot.
1 Vitale M, et al. Evaluation of the effects of a cosmetic treatment based on the secretion of Cryptomphalus aspersa 40% after the use of non-ablative fractional laser in skin aging. En: AAD (American Academy of Dermatology), Washington; 2019.